# NHS National Generic Pharmaceuticals - Clozapine

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Mylan
- Award value: £17,670,738
- Tender value: £8,979,884
- Award date: 5 August 2021
- Published: 6 September 2021
- Contract start: 1 August 2021
- Contract end: 31 July 2023
- Stage: awarded
- Procurement category: goods
- Notice ID: 42b7b7f5-98ab-41f7-baef-b6e28c3fe001-466196
- OCID: ocds-b5fd17-1a206321-9cf2-47a6-98e6-fcc05ff101ee

## Description

NHS National Generic Pharmaceuticals - Clozapine Offer reference number: CM/PHG/21/5634 Period of framework agreement: Dates detailed below, with an option or options to extend \(at the discretion of the Authority\) for a period or periods of up to 24 months\. Potential periods of call-offs under the framework agreement: 1st August 2021 to 31st July 2023

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [NHS Framework Agreement for South of England Branded - Tranche B and Annual](/contracts/ocds-b5fd17-4c9013e7-bbb5-4254-b8ad-705ccb4e5887): NHS England
- [NHS National Pharmaceuticals Transition 2021\_2 - Pemetrexed LSNE](/contracts/ocds-b5fd17-50f66811-fc34-4a5c-a6ba-6d48c9386892): NHS England
- [NHS Framework Agreement for Glatiramer acetate injection - North of England](/contracts/ocds-b5fd17-ed6126f2-1b57-433b-a8db-a858839857f8): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/42b7b7f5-98ab-41f7-baef-b6e28c3fe001-466196)